Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1183/13993003.03006-2020 http://scihub22266oqcxt.onion/10.1183/13993003.03006-2020 32883678!7474149!32883678     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Respir+J 2020 ; 56 (4): ä Nephropedia Template TP {{tp|p=32883678|t=2020. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome |pdf=|usr=}}{{32883678}} gab.com Text Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome JO: Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=32883678 #FOAvip Hypercytokinaemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels >/=80 pg.mL(-1) predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. https://bit.ly/3jq3uJ4 Twit Text FOAVip Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome ????Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=32883678 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32883678 #FOAvip English Wikipedia <ref>{{Cite pmid|32883678}}</ref> Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome #MMPMID32883678 Chen LYC; Hoiland RL; Stukas S; Wellington CL; Sekhon MS Eur Respir J 2020[Oct]; 56 (4): ä PMID32883678show ga Hypercytokinaemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels >/=80 pg.mL(-1) predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. https://bit.ly/3jq3uJ4 |Anti-Inflammatory Agents/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Betacoronavirus/pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/drug therapy/*immunology/mortality[MESH] |Cytokine Release Syndrome/drug therapy/*immunology[MESH] |Dexamethasone/therapeutic use[MESH] |Endothelium/*immunology[MESH] |Humans[MESH] |Immunologic Factors/therapeutic use[MESH] |Inflammation/*immunology[MESH] |Interleukin-6/*immunology[MESH] |Pandemics[MESH] |Pneumonia, Viral/drug therapy/*immunology/mortality[MESH] |Prognosis[MESH] |Respiratory Insufficiency/immunology[MESH] |SARS-CoV-2[MESH]Confronting the controversy: interleukin-6 and the COVID-19 cytokine s(epmc).pdf DeepDyve Pubget Overpricing